Nonselective β-blockers plus nitrates in portal hypertension: An open question
- 1 June 2003
- journal article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 37 (6), 1254-1256
- https://doi.org/10.1053/jhep.2003.50274
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Nadolol plus spironolactone in the prophylaxis of first variceal bleed in nonascitic cirrhotic patients: A preliminary studyHepatology, 2003
- Isosorbide mononitrate and propranolol compared with propranolol alone for the prevention of variceal rebleedingHepatology, 2000
- Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosisHepatology, 2000
- Pharmacological Treatment of Portal Hypertension: An Evidence-Based ApproachSeminars in Liver Disease, 1999
- Continuous prazosin administration in cirrhotic patients: Effects on portal hemodynamics and on liver and renal functionGastroenterology, 1995
- Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: Long-term hemodynamic and renal effectsHepatology, 1993
- Enhancement of Portal Pressure Reduction by the Association of Isosorbide–5–Mononitrate to Propranolol Administration in Patients With CirrhosisHepatology, 1990
- Propranolol in the Prevention of First Upper Gastrointestinal Tract Hemorrhage in Patients with Cirrhosis of the Liver and Esophageal VaricesNew England Journal of Medicine, 1987
- Increased Portal Venous Resistance Hinders Portal Pressure Reduction During the Administration of β–Adrenergic Blocking Agents in A Portal Hypertensive ModelHepatology, 1985
- Propranolol for Prevention of Recurrent Gastrointestinal Bleeding in Patients with CirrhosisNew England Journal of Medicine, 1981